Научном већу медицинског факултета универзитета у београду



бет3/4
Дата12.06.2016
өлшемі0.52 Mb.
#129934
1   2   3   4



* Према члану 37. Правилника: за реизбор у звање, кандидат је обавезан да у периоду од претходног избора оствари најмање половину од квантитативног минимума научноистраживачких резултата потребних за избор у то звање.



ЕЛЕМЕНТИ ЗА КВАЛИТАТИВНУ ОЦЕНУ НАУЧНОГ ДОПРИНОСА КАНДИДАТА



Пре избора у звање ВНС




Након избора у звање ВНС

Категорије

ДА

НЕ

ДА

НЕ

1. Награде и признања за научни рад




-




-

2. Уводна предавања на конференцијама и друга предавања по позиву




-

+ (9)*




3. Чланство у одборима међународних научних конференција и одборима међународних друштава

+ (1)




+ (1)




4. Чланство у уређивачким одборима часописа




-




-

5. Уређивање монографија




-




-

6. Рецензије научних радова у часописима са ISI SCI листе

+ (1)



+ (3)






7. Рецензије међународних научних пројеката




-




-

8. Цитираност


+ (248) укупно

9. Доприност развоју науке у земљи (формирање лабораторија, истраживачких група, отварање истраживачких праваца)





-




-

10. Руковођење пројектима, потпројектима, задацима

+ (1)




+ (1)




11. Менторство- магистарске тезе и докторске дисертације





-**




-**

12. Учешће у међународној сарадњи


+ (1)




+ (2)




13. Организација научних скупова


+ (2)




+ (2)





* Предавање на међународној конференцији (1) + предавање на скупу националног значаја (8)

** Кандидаткиња нема законско право да буде ментор магистарских теза и докторских дисертација

ЦИТИРАНОСТ ( 248 хетроцитата)
Marić I, Đurić VJ, Dimitrijević M, Bukilica M, Đorđević S, Marković BM, Janković BD. Stress induced resistance to anaphylactic schock. Int J Neurosci 1991; 59:159-66.


  1. García X, Martínez RD, González Díaz V, Tenorio Flores C, Gijón E. Effect of stress on the Schultz-Dale reaction in guinea pig aorta. Life Sci 1999; 64:2225-31.

  2. Palermo-Neto J, De Oliveira Massoco C, Robespierre De Souza W. Effects of physical and psychological stressors on behavior, macrophage activity, and Ehrlich tumor growth. Brain Behav Immun 2003; 17:43-54.

  3. Stankevicius D, Rodriges-Costa EC, Camilo-Florio J, Palermo-Neto J. Neuroendocrine, behavioral and macrophage activity changes induced by picrotoxin effects in mice. Neuropharmacology 2008; 54:300-8.


Bukilica M, Đorđević S, Marić I, Dimitrijević M, Marković BM, Janković BD. Stress induced suppresion of experimental allergic encephalomyelitis in the rat. Int J Neurosci 1991; 59:167-75.


  1. Ferry A, Le Page C, Rieu M. Sex as a determining factor in the effect of exercise on in vivo autoimmune response adjuvant arthritis. J Appl Physiol. 1994; 76:1172-5.

  2. Le Page C, Ferry A, Rieu M. Effect of muscular exercise on chronic relapsing experimental autoimmune encephalomyelitis. J Appl Physiol. 1994; 77:2341-7.

  3. Le Page C, Bourdoulous S, Beraud E, Couraud PO, Rieu M, Ferry A. Effect of physical exercise on adoptive experimental auto-immune encephalomyelitis in rats. Eur J Appl Physiol Occup Physiol 1996; 73:130-5.

  4. Moynihan JA, Ader R. Psychoneuroimmunology: Animal models of disease. Psychosom Med 1996; 58:546-58.

  5. Owhashi M, Shouzui Y, Arita H. Stress down-regulates experimental allergic encephalomyelitis (EAE) but permits activation and localization of autoreactive vβ8.2+ T cells. Int J Neurosci 1997; 89:177-88.

  6. Weidenfeld J, Karussis D, Abramsky O, Lehmann D, Arbell I, Ovadia H. Linomide activates the adrenocortical axis in the rat: Inhibition of experimental autoimmune encephalomyelitis by linomide is not related to the increase of corticosterone. J Neuroimmunol 1997; 79:49-53.

  7. Correa SG, Rodriguez-Galán MC, Rivero VE, Riera CM. Chronic varied stress modulates experimental autoimmune encephalomyelitis in Wistar rats. Brain Behav Immun 1998; 12:134-48.

  8. García X, Martínez RD, González Díaz V, Tenorio Flores C, Gijón E. Effect of stress on the Schultz-Dale reaction in guinea pig aorta. Life Sci 1999; 64: 2225-31.

  9. Harbuz MS. Chronic inflammatory stress. Baillieres Best Pract Res Clin Endocrinol Metab 1999; 13:555-65.

  10. Campbell T, Meagher MW, Sieve A, Scott B, Storts R, Welsh TH, Welsh CJR. The effects of restraint stress on the neuropathogenesis of Theiler's virus infection: I. Acute disease. Brain Behav Immun 2001; 15:235-54.

  11. Chandler N, Jacobson S, Esposito P, Connolly R, Theoharides TC. Acute stress shortens the time to onset of experimental allergic encephalomyelitis in SJL/J mice. Brain Behav Immun 2002; 16:757-63.

  12. Bomholt SF, Harbuz MS, Blackburn-Munro G, Blackburn-Munro RE. Involvement and role of the hypothalamo-pituitary-adrenal (HPA) stress axis in animal models of chronic pain and inflammation. Stress 2004; 7:1-14.

  13. Sieve AN, Steelman AJ., Young CR, Storts R, Welsh TH, Welsh CJR, Meagher MW. Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice. J Neuroimmunol 2004; 155:103-18.

  14. Esquifino AI, Cano P, Jiménez V, Cutrera RA, Cardinali DP. Experimental allergic encephalomyelitis in male Lewis rats subjected to calorie restriction. J Physiol Biochem 2004; 60:245-52.

  15. Mohr DC, Pelletier D. A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain Behav Immun 2006; 20:27-36.

  16. Heesen C, Gold SM., Huitinga I, Reul JMHM. Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis –A review. Psychoneuroendocrinology 2007; 32:604-18.

  17. White LJ, Castellano V. Exercise and brain health-Implications for multiple sclerosis: Part II-Immune factors and stress hormones. Sports Med 2008; 38:179-86.

  18. Ishikawa H, Ito S, Nishio N, Yuzawa Y, Matsuo S, Isobe K. Injection of bleomycin in newborn mice induces autoimmune sialitis that is transferred by CD4 T cells. Immunology and Cell Biology 2009; 87:351-8.

  19. Nunez-Iglesias MJ, Novio S, Almeida-Dias, Fereire-Garabal M. Inhibitory effects of alprazolam on the development of acute experimental autoimmune encephalomyelitis in stressed rats. Pharmacol Biochem Behav 2010; 97:350-6.

  20. Meagher MW, Sieve AN, Johnson RR et al. Neonatal maternal separation alters immune, endocrine and behavioral responses to acute Theiler's virus infection in adult mice. Behav Genet 2010; 2:233-49.

  21. Ajami B, Bennett JL, Krieger C et al. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 2011; 14:1142-9.


Đorđević S, Bukilica M, Dimitrijević M, Marković BM, Janković BD. Anti-myelin basic protein autoantibodies in rats stressed by overcrowding. Ann NY Acad Sci 1992; 650:302-6.


  1. Evans HL. Markers of neurotoxicity: from behavior to autoantibodies against brain proteins. Clin Chem 1995; 41:1874-81.

  2. De Bellis MD, Burke L, Trickett PK, Putnam FW. Antinuclear antibodies and thyroid function in sexually abused girls. J Trauma Stress 1996; 9:369-78.

  3. Burger H, Kaiser HE. Crowding. In Vivo 1996; 10:249-54.

  4. Hurst JL, Barnard CJ, Tolladay U, Nevision CM, West CD. Housing and welfare in laboratory rats: Effects of cage stocking density and behavioral predictors of welfare. Anim Behav 1999; 58:563-86.

  5. Knyazeva SI, Loginova NA, Loseva EV. Anxiety and body weight in rats living in overpopulated cages. Bull Exp Biol Med 2012; 154:7-10.


Andrejević S, Bukilica M, Dimitrijević M, Laban O, Radulović J, Kovačević-Jovanović V, Stanojević V, Vasiljević T, Marković BM. Stress-induced rise in serum anti-brain autoantibody levels in the rat. Int J Neurosci 1997; 89:153-64.


  1. Zhou Y, Cheshire A, Howell LA, Ryan DH, Harris RBS. Neuroautoantibody immunoreactivity in relation to aging and stress in apolipoprotein E-deficient mice. Brain Res Bull 1999; 49:173-9.

  2. Landriscina M, Soldi R, Bagalá C, Micucci I, Bellum S, Tarantini F, Prudovsky I, Maciag T. S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro. J Biol Chem 2001; 276: 22544-52.

  3. Loseva EV, Loginova NA, Mezentseva MV, Klodt PM, Kudrin VS. Immunological parameters of the blood and monoamine content in the brain of rats during long-term overcrowding. Bull Exp Biol Med 2013;155:470-3.


Stefanović Lj, Bogić M, Balaban J, Mitrović O, Stošović R, Andrejević S. Mesto i uloga ćelija endotela u reakcijama alergijske inflamacije. Srp Arh Celok Lek 1998; 126:138-44.


  1. Narayanan K, Jaramillo A, Phelan DL, Mohanakumar T. Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway. Eur J Immunol 2004; 34:2303-12.

  2. Jubeli E, Moine L, Vergnaud-Gauduchon J, Baratt G. E-selectin as target for drug delivery and molecular imaging. J Control Rel 2012; 158:194-206.


Drulović J, Dujmović I, Stoisavljević N, Tripković I, Apostolski S, Lević Z, Mostarica-Stojković M, Bonači B, Andrejević S. Transverse myelopathy in the antiphospholipid antibody syndrome: pinworm infestation as a trigger? J Neurol Neurosurg Psychiatry 2000; 68:249.


  1. St Georgiev V. Chemotherapy of enterobiasis (oxyuriasis). Expert Opin Pharmacother 2001; 2:267-75.

  2. Kerr DA, Ayetey H. Immunopathogenesis of acute transverse myelitis. Curr Opin Neurol 2002; 15:339-47.

  3. Thomson J.C. Pelvic pain caused by intraperitoneal Enterobius vermicularis (threadworm) ova with an associated systemic autoimmune reaction. J Obstet Gynaecol Res 2004; 30:90-5.

  4. Putruele AM, Legarreta CG, Limongi L, Rossi SE. Tuberculous transverse myelitis: Case report and review of the literature. Clin Pulm Med 2005; 12:46-52.

  5. Krishan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse myelitis. Clinical manifestations, pathogenesis, and management. In: Minagar A, Alexander JS. (Eds.) Current clinical Neurology: Inflammatory disorders of the nervous system: Pathogenesis, Immunology and clinical management.. Humana Press Inc, Totowa, NJ, 2005, 217-36.

  6. Heinzlef O, Roullet E. Acute myelopathy [Myélopathies aiguës]. EMC – Neurologie 2005; 2:526-43.

  7. Tsibouris P, Galeas T, Moussia M, Sotiropoulou M, Michopoulos S, Kralios N. Two cases of eosinophilic gastroenteritis and malabsorption due to Enterobious vermicularis. Dig Dis Sci 2005; 50:2389-92.

  8. Baar I, Jacobs BC, Govers N, Jorens PG, Parizel PM, Cras P. Campylobacter jejuni-induced acute transverse myelitis. Spinal Cord 2007; 45:690-4.

  9. Kaira V, Sharma S, Sahu J, Sankhvan N, Chaudhry R, Dhawan B. Childhood acute transverse myelitis: clinical profile, outcome, and association with antiganglioside antibodies. J Child Neurol 2009; 24:466-71.

  10. Borchers AT, Gershwin ME. Transverse myelitis. Autoimm Rev 2012; 11:231-48.

  11. Beh SC, Greenberg BM, Frohman T, Frohman EM. Transverse myelitis. Neurol Clinics 2013; 31:79-138.

  12. Accapezzato D, Paroli M. Barnaba V. A rare case of reactive arthritis associated with Enterobius vermicularis infection. Int J Rheum Dis. 2013; 16:602-3.


Buklica MN, Andrejević SB, Bonači-Nikolić BM, Nikolić MM. Speckled antinuclear antibodies in keratinocytes-what does it mean? Clin Exp Rheum 2002; 20:499-504.


  1. Rao R, Balachandran C. Epidermal nuclear staining: A distinct reaction pattern in connective tissue diseases. Indian J Dermatol Venereol Leprol 2007; 73:120-1.

  2. Sousa JX, Miyamoto D, Zimbres JM, Costa DV, Aoki V. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence. Clin Exp Derm 2009; 34:314-8.

  3. Medenica Lj, Skiljevic D. Dijagnosticki znacaj imunofluorescentnih testova u dermatologiji. Medicinski pregled 2009; 62:539-46.


Andrejević S, Bonači-Nikolić B, Bukilica M, Nikolić MM. Autoantibodies to human nuclear lamin B1 in systemic lupus erythematosus: comment on the article by Senecal et al. (Letter to the Editor) Arthritis Rheum 2000; 43:950-1.


  1. Pistillo MP, Tazzari PL, Gaudiano C, Cilla V, Kato T, Matsui T, Nishioka K, Capanni P, Conte R, Ferrara GB. Patients with neoplastic and nonneoplastic hematologic diseases acquire CTLA-4 antibodies after blood transfusion. Transfusion 2001; 41:462-9.


Bonači-Nikolić B, Andrejević S, Bukilica M, Nikolić MM. Clinical and prognostic value of antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and microscopic polyangiitis: comment on the article by Russell et al. (Letter) Arthritis Rheum. 2002; 46:278-80.


  1. Kamali S, Inanc M, Gul A, et al. Systemic necrotizing vasculitides in Turkey: a comparative analysis of 40 consecutive patients. Reumatol Int 2005; 26:16-20.


Andrejević S, Bonači-Nikolić B, Bukilica M, Macut Đ, Miljic P, Pavlovic M, Đukić P, Nikolic MM, Havelka M. Intracardiac thrombosis and fever possibly triggered by ovulation induction a patient with antiphospholipid antibodies. Scand J Rheum 2002; 31:249-51.


  1. Marie I, Derumeaux G, Delahaye F, Mouton-Schleifer D, Reumont G, Levesque H, Courtois H. Intracardiac thrombi in primary antiphospholipid syndrome: Two case reports. Eur J Intern Med 2003; 14:504-8.

  2. Ou Y-C, Kao Y-L, Lai S-L, Kung F-T, Huang F-J, Chang S-Y, Chang Chien C-C. Thromboembolism after ovarian stimulation: Successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: Case report. Hum Reprod 2003; 18:2375-81.

  3. Marai I, Zandman-Goddard G, Shoenfeld Y. The systemic nature of the antiphospholipid syndrome. Scand J Rheumatol 2004; 33:365-72.

  4. Al-Halaseh W, Shah AN, DeGregorio J. Right ventricular thrombus mimicking a myxoma in 19-year-old man. Hosp Physician 2005; 56:39-42.

  5. Rao A.K, Chitkara U, Milki AA. Subclavian vein thrombosis following IVF and ovarian hyperstimulation: A case report. Hum Reprod 2005; 20:3307-12.

  6. Fernández-Llanio N, Alegre-Sancho JJ, Chalmeta-Verdejo C, Fernández-Carballido C, Román-Ivorra JA. Hormone therapy, fertility and pregnancy in antiphospholipid syndrome [Terapias hormonales, fertilidad y embarazo en el síndrome antifosfolipídico]. Reumatologia Clinica 2006; 2:90-106.

  7. Sammaritano LR. Infertility and Antiphospholipid Antibodies (review chapter). In: Khamashta MA. (Ed.) Hughes syndrome, Second Edition. Springer, London; 2006. pp. 196-208.

  8. Girolami A, Scandellari R, Tezza F, Paternoster D, Girolami B. Arterial thrombosis in young women after ovarian stimulation: case report and review of the literature. J Thromb Thrombolysis. 2007; 24:169-74.

  9. Bellver J, Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertil Steril 2009; 92:1803-10.


Andrejević S, Bonači-Nikolić B, Bukilica M, Milivojević G, Bašanović J, Nikolić MM. Purpura and leg ulcers in a patient with cryoglobulinaemia, non-Hodgkin's lymphoma and antiphospholipid syndrome. Clin Exp Derm 2003; 28:151-3.


  1. Jardin F, Lévesque H, Tilly H. Auto-immune manifestations in non-Hodgkin's lymphoma [Manifestations dysimmunitaires associées aux lymphomas]. Rev Med Interne 2005; 26:557-71.

  1. Anderson J, Hanson D, Langemo D, Hunter S, Thompson P. Atypical wounds: recognizing and treating the uncommon. Adv Skin Wound Care. 2005; 18:468-70.

  2. Gómez-Puerta JA, Cervera R, Espinosa G, Aguiló S, Bucciarelli S, Ramos-Casals M, Ingelmo M, Asherson RA, Font J. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum 2006; 35:322-32.

  3. Funauchi M, Yamagata T, Sugiyama M, Ikoma S-Y, Sakaguchi M, Kinoshita K, Kawata A. A case of antiphospholipid antibody syndrome that manifested in the course of basal cell carcinoma. Mod Rheumatol 2007; 17:153-5.

  4. Jardin F. Development of autoimmunity in lymphoma. Exp Rev Clin Immunol 2008; 4: 247-66.

  5. Casato M, Carlesimo M, Francia A, Timarco C, Antenucci A et al. Influence of inherited and acquired thrombophilic defects on the clinical manifestations of mixed cryoglobulinaemia. Rheumatology 2008; 47: 1659-63.

  6. Pham C, Shen Y-M. Antiphospholipid antibodies and malignancy. Hematol Oncol Clin North Am 2008: 22:121-30.

  7. Taher ZA, Brassard A. Venous leg ulcer in a 42-year-old woman: What should we think about? J Cutan Med Surg 2009; 13 (Suppl. 1):20-5.

  8. Gerkowicz A, Chodorowska G, Michalak-Stoma A, Juszkiewicz-Borowiec M, Krasowska D, Niewiedzioł M. Antiphospholipid syndrome - Clinical manifestation, diagnostics and literature review.  Post Dermatol Alergol 2010;1: 69–75.

  9. Jeon SY, Ko DY, Hong JW, Lee KY, Kim KH, Song KH. Cryoglobulinemia associates with gastric diffue large B cell lymphoma. Kor J Derm 2011; 49:1087-92.

  10. Altunay I, Ates B, Atis G, Ton O. Cryoglobulinaemic leg ulcers associated with transient ischaemic attack. J Wound Care 2012; 21:38-40.


Bećarević M, Andrejević S, Bonači-Nikolić B, Obradović I, Miljić P, Majkić-Singh N. Anti-oxLDL antibodies –marker for arterial thromboses in antiphospholipid syndrome. Clin Lab 2005; 51:279-283.


  1. Morrow KJ, Bawa R, Wei C. Recent advances in basic and clinical nanomedicine. Med Clin North Am 2007; 91:805-43.

  1. Krause I, Leibovici L, Blank M, Shoenfeld Y. Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis. Lupus 2007; 16:176-80.

  2. Belizna C, Lartigue A, Favre J, Gilbert D, Tron F et al. Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome? Lupus 2008; 17: 185-94.

  3. Lobo JC, Mafra D, Abdalla DSP. Oxidative changes of LDL in chronic kidney disease: focus on electronegative LDL. J Bras Nefrol 2008; 30:294-300.

  4. Merrill, J.T. Chapter 14 Antiphospholipid Antibodies and Atherosclerosis. Handbook of Systemic Autoimmune Diseases Vol. 10, pp. 169-183. Series Editor: Asherson RA. Elsevier 2009.

  5. Ames PRJ, Matsuura E, Batuca RJ, Ciampa A, Lopez LL, Ferrara F, Iannaccone L, Delgado Alves J. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome. Lupus 2010; 19:711.


Bonači-Nikolić B, Nikolić MM, Andrejević S, Zorić S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 2005; 7: R1072-81.


  1. Wiik A. Clinical and laboratory characteristics of drug-induced vasculitic syndromes. Arthritis Res Ther 2005; 7:191-2.

  2. Suresh E. Diagnostic approach to patients with suspected vasculitis. Postgrad Med J 2006; 82:483-8.

  3. Chen Y-X, Yu H-J, Ni L-Y, Zhang W, Xu Y-W at al. Propilthyouracil-associated antineutrophil citoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases. J Rheumatol 2007; 34:2451-6.

  4. Rivkees SA. Graves’ disease therapy in children: truth and inevitable consequences. J Pediatr Endocrinol Metab 2007; 20: 953-5.

  5. Borchers A, Keen CL, Gershwin ME. Drug-induced lupus. Ann NY Acad Sci 2007; 1108:166-82.

  6. Wiik AS. Diagnostic strategies for autoimmune rheumatic diseases [Diagnostische strategien bei rheumatischen autoimmunerkrankungen] Z Rheumatol 2007; 66:219-24.

  7. Tsuboi, K., Ueshiba, H., Shimojo, M., Ishikawa, M., Watanabe, N., Nagasawa, K., Yuasa, R., Yoshino, G.E.N. The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease. Endocr J 2007; 54:39-43.

  8. Pietszkowski NC, De Carvalho GA, De Souza HN., Werka CR, Borazo LA, Graf H, De Carvalho M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune disease induced by propylthiouracil [Auto-imunidade ANCA (anticorpo anti-citoplasma de neutrófilos) positiva induzida por propiltiouracil: Relato de caso e revisão da literatura] Arq Bras Endocrinol Metabol 2007; 51:136-41.

  9. Storsley L, Geldenhuys L. Ciprofloxacin-induced ANCA-negative cutaneous and renal vasculitis - Resolution with drug withdrawal. Nephrol Dial Transplant 2007; 22:660-1.

  10. Papiris SA, Manali ED, Kalomenidis I, Kapotsis GE, Karakatsani A, Roussos C. Bench-to-bedside review: Pulmonary-renal syndromes - an update for the intensivist. Crit Care. 2007; 11:213.

  11. Jannette JC, Thomas DB. Pauci-immune and antineutrophil cytoplasmic autoantibody mediated crescentic glomerulonephritis and vasculitis. In: Hepinstall’s pathology of the kidney, 6th edition. Lippincot, Williams & Wilkins 2007.

  12. Pelletier L, Saoudi A, Fournie G. Toxin-induced immunological renal disease (Chapter). In: De Broe ME, Porter GA (Eds.) Clinical nephrotoxins: Renal injury from drugs and chemicals. Third Edition. Springer US; 2008. pp. 131-53.

  13. Wiik A. Drug-induced vasculitis. Curr Opin Rheum 2008; 20: 35-9.

  14. Ogura T. Clinical features of MPO-ANCA-positive interstitial pneumonia. Jpn J Chest Dis 2008; 67:189-201.

  15. Mitrović-Vergles J, Galešić K, Čulo MI, Vergles D, Ljubanović D. Hyperthyroidismus and pyoderma gangrenosum: a case report. Endocrinologist 2008; 18: 109-10.

  16. Eiras P. Anti-neutrophil cytoplasmic antibodies: Other target antigens. Seminarios de la Fundacion Espanola de Reumatologia 2008; 9:156-65.

  17. Marie I. Drug-induced and toxic vasculitis and pseudo-connectivitis. Med Tharap 2008; 14:247-53.

  18. Tripodi PF, Ruggeri RM, Campenni A, Cucinotta M, Mirto A et al. Central nervous system vasculitis after starting methimazole in a woman with Graves’ disease. Thyroid 2008; 18:1011-3.

  19. Milanez FM, Costa LAG, Jose FF, Enokihara MMSS, de Souza AWS. Propylthyouracil-induced cutaneous vasculitis. Rev Bras Rheumatol 2008; 48: 55-8.

  20. Mehindiratta MM, Pandey RS, Kushwaha RS, Mehndiratta P. Carbimazole induced ANCA positive vasculitis. JAPI 2008; 56: 801-3.

  21. Gao Y, Chen M, Ye H, Yu F, Guo X-h, Zhao M-h. Long term outcomes of patients with propylthiouracil-induced anti-neutrophyl cytoplasmic auto-antibody-associated vasculitis. Rheumatology 2008; 47:1515-20.

  22. Ball GV, Bridges SL. Pathogenesis of Vasculitis (Chapter 7). In: Vasculitis, 2nd edn Oxford University Press, Oxford 2008.

  23. Gao Y, Zhao MH. Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology 2009; 14:33-41.

  24. Cin MO, Gursoy A, Morris Y, Ajdintug OT, Kamel N. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Grave’s patients treated with propilthiouracil. Int J Clin Pract 2009; 63:299-302.

  25. Loh AHL, Cohen AH. Drug-induced kidney disease - Pathology and current concepts. Ann Acad Med Singapore 2009; 38:240-50.

  26. Tsuboi K, Ishihara Y, Ishikawa M, Tsuchida Y, Nagasawa K et al. Unusual oral ulceration, skin rash, and fever in a patient receiving propylthiouracil. Thyroid 2009; 19:421-2.

  27. Yokogawa N, Vivino FB. Hydralazine-induced autoimmune disease: Comparison to idiopathic lupus and ANCA-positive vasculitis. Mod Rheumatol 2009; 19:338-47.

  28. John R, Harzenberg AM. Renal toxicity of tharapeutic drugs. J Clin Path 2009; 62:505-15.

  29. Pressler BM, Rrobarge ME, Anderson KI. Partial characterization of feline myeloperoxidase and investigation of its potential role as an autoantigen in hyperthyroid cats. Am J Vet Res 2009; 70: 869-78.

  30. Pasquet F, Pavic M, Mounier C, Karkowski L, Colle B. Antineutrophil cytoplasmic antibody associated vasculitis: An uncommon side effect of propylthiouracil. Rev Med Intern 2009; 30:882-5.

  31. Kabiraj M, Khoja W, Hussain K. An acute handshake ulnar mononeuropathy. Neurosci 2009; 14:391-393.

  32. Bowers B, Gupta D, Patel H, Mirza N. Exophthalmos as a presenting manifestation of limited Wegener's granulomatosis in a patient with prior Graves' disease. Clin Med: Case Rep 2009; 2:35-37.

  33. Gatenby PA, Lucas RM, Engelsen O, Ponsonby A-L, Clemens M. Antineutrophil cytoplasmic antibody-associated vasculitides: Could geographic patterns be explained by ambient ultraviolet radiation? Arth Care Res 2009; 61:1417-24.

  34. Kluger N, Frances C. Cuteneous vasculitis and their differential diagnoses. Clin Exp Rheumatol 2009; 27:124-38.

  35. Wiik A. Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes. Mod Rheumatol 2009; 19:590-9.

  36. Horai Y, Miyamura T, Takahama S et al. Microscopic polyagiitie in a patient on hemodialysis: a case report. Jpn Journal Clin Immunol 2009; 32:506-10.

  37. Žarković M. Medikamentozna terapija poremećaja funkcije štitaste žlezde. Arhiv za farmaciju 2010; 60:149-57.

  38. Galdiero MR, Triggianese P, Varricchione G, Spadaro G, Genovese A. Drug hypersensitivity reactions. Part I. Cutaneous manifestations. Ital J Allerg Clin Immunol 2010; 20:30-9.

  39. Sangala N, Lee RW, Horsfield C, Goldsmith DJA. Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine: a timely reminder of an old foe. Int Urolog Nephr 2010; 42; 503-6.

  40. Yip G, Ekinci E, Lee ST, Jerums G, Grossman M. Carbimazole-induced agranulocytosis: does antineutrophil cytoplasmic antibody have a role? Int Med J 2010; 40:300-3.

  41. Rivkees SA, Szarfman A. Dissimilar Hepatotoxicity Profiles of Propylthiouracil and Methimazole in Children. JCEM 2010; 95: 3260-7.

  42. Csernok E, Lamprecht P, Gross WL. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol 2010; 22: 43-8.

  43. Esquivel-Valerio JA, Flores-Suarez LF, Rodriges-Arnado J, et al. Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected alter treatment initiation. Clin Exp Rheum 2010; 28:S35-9.

  44. Calhan T, Senates E, Cebeci E, Zuhur SS, Ozbakir F, Gorpe U. A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism. Endocrine 2010; 2: 199-205.

  45. Wiik AS. Autoantibodies in ANCA-associated vasculitis. Rheum Dis Clin North Am 2010; 36:479-89.

  46. Urlich K, Koval R, Koval E, Bapoje S, Hirsh J. Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. JCR 2011; 17:193-6.

  47. Yu-Ling T, Yi-Chan T, Ling-Long H, Tsung-Chieh Y. Ocult pulmonary hemorrhahage as a rare presentation of propylthiouracil-induced vasculitis. Pediatrics 2011; 127:245-9.

  48. Chang C, Gershwin ME. Drug-induced lupus erythematosus: incidence, management and prevention. Drug Safety 2011; 34: 357-74.

  49. Morais P. Baudrier T, Mota A, Cunha AP, Alves M, Celestino N, Joaao C, Saa-Couto P, Azevedo F. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature. Cutan Ocul Toxicol 2011; 30:147-53.

  50. McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. CJASN 2011; 6: 2799-805.

  51. Pinto M, Manrique H. Vasculitis inducida por metimazol. Reporte de caso. Rev Med Hered 2011: 22: 147-50.

  52. Marques VMSM, Carvalho SCD, Antunes AMMMP, Marques OAMCCP, Silva MHF, Veira MJC. Doenca de Graves associda a artrite idiopatiuca juvenil. Rev Bras Rheumatol 2011; 51: 187-9.

  53. Radic M, Martinovic Kaliterna D, Radic J. Drug-induced vasculitis: a clinical and pathological review. The Neth J Med 2012; 70:12-7.

  54. Wakamatsu K, Mitsuhashi Y, Yamamoto T, Tsuboi R. Propylthiouracil-induced antineutrophil cytoplasmic antibody positive vasculitis clinically mimicking pyoderma gangrenosum. J Dermatol 2012; 39:736-8.

  55. Khan NA, Singh M. Development of anti-neutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves’ disease independent of anty-thyroid drug therapy. Mod Rheum 2012; 22:778-82.

  56. Shin K. Approach to vasculitides. Chapter 11, Birgham and Women’s Experts Approach to Rheumatology, 2012, Pages 137-150, Coblyn JS, Weinblatt M, Helfgott S and Bermas B (Eds.) Jones and Barlett Publishers.

  57. Celzada Algravez JL, Ramirez HJ, Marquez GD, Diaz DMM. Wegener granulomatosis: report of a case and review of the literature. Med Int Mex 2012; 28:504-7.

  58. Chen M, Gao Z, Guo XH, Zhao MH. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Nat Rev Nephrol 2012; 8:476-83.

  59. Veerappan I, Prabitha EN, Abraham A, Theodore S, Abraham G. Double ANCA-positive vasculitis in a patient with infective endocarditis. Indian J Nephrol 2012; 22:469-72.

  60. Bilge NSY, Kasifoglu T, Korkmaz C. PTU-induced ANCA-positive vasculitis: an innocent or a life threatening adverse effect? Rheum Int 2013; 33:117-120.

  61. Mavrakanas TA, Bouatou Y, Samer C, Seigneux S, Meyer P. Carbimazole-induced , ANCA-associated, crescetic glomerulonephritis: case report and literature review. Renal Failure 2013; 35:414-7.

  62. Omair MA, Mohamed N, Johnson SR, Ahmad Z, Lee P. ANCA-associated vasculitis in systemic sclerosis report 3 cases. Rheumatol Int 2013; 33:139-43.

  63. Ogura T, Hebisawa A. ANCA related intestitial pneumonia. Jpn J Chest Dis 2013; 72:S248-55.

  64. Baser H, Tuzun D, Balkan F, Dirikoc A, Saglam F, et al. Myeloperoxidase and proteinase-3 antineutrophil cytoplasmic antibody titers in graves' disease patients treated with propylthiouracil. Acta Endorinol 2013; 9:543-50.

  65. Silva SV, Ferreira JP, Carvalho S, Seabra F, Marinho A. Antineutrophil cytoplasmatic antibody positive systemic vasculitis in a patient treated with propylthiouracil. Acta Rheumatol Port 2013; 38:302-5.

  66. Kakita T, Nagatoya K, Takimoto H, Matsuda H, Mori T, et al. Antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis with membranous nephropathy treated using thiamazole. CEN Case Rep 2013; 2:165-9.

  67. Yuste C, Rapalai M, Pritchard BA, Jones TJ, Amosail C, et al, Overlap between dermatomyositis and ANCA vasculitides. Clin Kidney Int 2014; 7:59-61.

  68. Deane KD, El-Gabalwy H. Patogénesis and prevention of rheumatic disease: focus on preclinical RA and SLE. Nat Rev Rheumatol 2014; doi: 10.1038/nrrheum.2014.6.

  69. Lamprecht P, Holl-Urlich K, Greoss WL. Granulomatosis with polyangiitis (Wegener’s granulomatosis)-pathogenesis. In: Oxford Textbook of Vasculitis, 3rd edition. Oxford University Press 2014.



Достарыңызбен бөлісу:
1   2   3   4




©dereksiz.org 2024
әкімшілігінің қараңыз

    Басты бет